Cull et al. showed Th1-like immune responses, which were associated with the production of IFN-γ; however, an Id-specific CTL response was absent upon DC-based therapy and GM-CSF in advanced refractory MM patients [126]. This evidence concerns the gene CSF2 and Miyoshi myopathy.